Rhythm Pharmaceuticals (RYTM) Intangibles (2021 - 2025)
Historic Intangibles for Rhythm Pharmaceuticals (RYTM) over the last 5 years, with Q3 2025 value amounting to $5.5 million.
- Rhythm Pharmaceuticals' Intangibles fell 1338.45% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 1338.45%. This contributed to the annual value of $6.2 million for FY2024, which is 1215.14% down from last year.
- Latest data reveals that Rhythm Pharmaceuticals reported Intangibles of $5.5 million as of Q3 2025, which was down 1338.45% from $5.7 million recorded in Q2 2025.
- In the past 5 years, Rhythm Pharmaceuticals' Intangibles registered a high of $8.5 million during Q1 2022, and its lowest value of $4.7 million during Q4 2021.
- Its 5-year average for Intangibles is $6.6 million, with a median of $6.6 million in 2024.
- As far as peak fluctuations go, Rhythm Pharmaceuticals' Intangibles surged by 7054.0% in 2022, and later plummeted by 1338.45% in 2025.
- Rhythm Pharmaceuticals' Intangibles (Quarter) stood at $4.7 million in 2021, then soared by 69.24% to $7.9 million in 2022, then dropped by 10.85% to $7.0 million in 2023, then fell by 12.15% to $6.2 million in 2024, then dropped by 10.38% to $5.5 million in 2025.
- Its Intangibles was $5.5 million in Q3 2025, compared to $5.7 million in Q2 2025 and $6.0 million in Q1 2025.